PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Nov-2022 Arrowhead Sells Royalty Interest in Olpasiran to Royalty Pharma for $250 Million and Future Milestones Businesswire
09-Nov-2022 North America Genotyping Market Report 2022: Use of Genotyping in Drug Development for Genetic and Rare Diseases Drives Growth - ResearchAndMarkets.com Businesswire
09-Nov-2022 メルク、シナジス、IPSがコンプライアンスと検証を簡素化する技術文書管理について発表 Businesswire
09-Nov-2022 SugarCRM Announces 2022 Customer Breakthrough Award Winners for the Americas and Asia Pacific Businesswire
09-Nov-2022 Revance to Participate in the Stifel 2022 Healthcare Conference Businesswire
09-Nov-2022 Twill Deepens Telebehavioral Health Offering with e-Psychiatry Partnership Businesswire
09-Nov-2022 UroGen Announces the Appointment of Dan Wildman to the UroGen Pharma Board of Directors Businesswire
09-Nov-2022 Vertex to Participate in Upcoming Investor Conferences Businesswire
09-Nov-2022 Digital Health Reshaping MedTech Industry as Consumers Demand “Anywhere, Everywhere” Healthcare, Accenture and AdvaMed Report Finds Businesswire
09-Nov-2022 NuroKor secures US market-first with launch of equine bioelectronic therapy system NuroKor
09-Nov-2022 Bionik Laboratories Reports Second Quarter Fiscal Year 2023 Financial Results Businesswire
09-Nov-2022 Areteia Therapeutics announces the appointment of Christopher Courts, CPA as Chief Financial Officer Businesswire
09-Nov-2022 Innovations in Direct Air Carbon Capture, Wearables Soft Robotics, Co-ventilation Systems and Diagnostic Devices - ResearchAndMarkets.com Businesswire
09-Nov-2022 Global Sustainable Packaging Market Report 2022: Increasing Bans on Single-Use Plastics Catalyze Sector Growth - ResearchAndMarkets.com Businesswire
09-Nov-2022 Multi-omics Startup Pleno Inc. Continues to Strengthen its Board of Directors Businesswire
09-Nov-2022 Silence Therapeutics to Present at Jefferies London Healthcare Conference Businesswire
09-Nov-2022 Aktana Named Trailblazer in Commercial Analytics & AI Assessment by Everest Group Businesswire
09-Nov-2022 GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2022 Businesswire
09-Nov-2022 Enanta Pharmaceuticals Initiates SPRINT, a Phase 2 Clinical Trial of EDP-235, its Oral, Direct-Acting Antiviral Protease Inhibitor Specifically Designed for the Treatment of COVID-19 Businesswire
09-Nov-2022 Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Financial Guidance Businesswire